메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
류재곤 (성균관대학교 삼성창원병원) 김소영 (고신대학교복음병원) 박수신 (우석대학교 약학대학) 제남경 (부산대학교)
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제32권 제4호
발행연도
2022.12
수록면
313 - 320 (8page)
DOI
https://doi.org/10.24304/kjcp.2022.32.4.313

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Serotonin syndrome is a life-threatening disease if not appropriately treated. This study aimed to investigate theprescription status of contraindicated drug combinations that cause serotonin syndrome and identify the related factors. Methods: Across-sectional study was conducted using nationwide claims data. Adult patients taking serotonergic drugs with Parkinson’s diseaseor mental disorders were selected. Based on international medical databases (MDBs) and the Korean Drug Utilization Review(DUR), the status of prescribing contraindicated drug combinations that induce serotonin syndrome, the related factors, and thedifference between international MDBs and the Korean DUR were analyzed. Results: Of the 49,773 study subjects, 163 (0.3%) wereprescribed contraindicated serotonergic drug combinations based on international MDBs, and among them, only 105 (64.4%) werecontraindicated by the Korean DUR. Positive influencing factors for prescribing contraindicated drug combinations include patientage between 65 and 74 and physician’s specialties (neurologists, and orthopedists). Negative influencing factors were physician’sspecialty (internists) and medical institution (primary institutions). Conclusion: Despite the implementation of DUR, 3 out of 1,000study subjects received contraindicated drug combinations that caused serotonin syndrome. Hence, it is necessary to comply with theDUR and improve it in accordance with international MDBs.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0